1991
DOI: 10.1128/aac.35.9.1804
|View full text |Cite
|
Sign up to set email alerts
|

Cloning and nucleotide base sequence analysis of a spectinomycin adenyltransferase AAD(9) determinant from Enterococcus faecalis

Abstract: (9) was compared with that of the AAD(9) encoded by staphylococcal transposon Tn554. The two proteins shared approximately 39% amino acid identity, which was expanded to 53% when conservative amino acid changes were included. When the streptococcal protein was compared with an AAD(3')(9) protein of E. coli, the degrees of identity were 27 and 47%, on the basis of actual amino acids and conservative replacements, respectively. The cloning and nucleotide base sequence analyses of the spectinomycin AAD(9) determi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
107
0

Year Published

1997
1997
2006
2006

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 154 publications
(107 citation statements)
references
References 27 publications
0
107
0
Order By: Relevance
“…Insertion-duplication mutagenesis using the pJDC9-derivative pEGR91 containing an internal fragment of the ciaR gene has been described (14). Alternatively, the gene was disrupted by insertion of the spectinomycin resistance gene aad9 from pDL278 (31), and no differences in phenotypes from the pJDC9 derivative was noted. The R6ciaR null (Spc r ) mutant (R6ciaR::aad9) has been described (36).…”
Section: Methodsmentioning
confidence: 99%
“…Insertion-duplication mutagenesis using the pJDC9-derivative pEGR91 containing an internal fragment of the ciaR gene has been described (14). Alternatively, the gene was disrupted by insertion of the spectinomycin resistance gene aad9 from pDL278 (31), and no differences in phenotypes from the pJDC9 derivative was noted. The R6ciaR null (Spc r ) mutant (R6ciaR::aad9) has been described (36).…”
Section: Methodsmentioning
confidence: 99%
“…S. pneumoniae D39 derivatives with replacement mutations in the psa genes were constructed by using plasmid pCZA342 (Hoskins et al, 1999), which encodes apramycin (for selection in E. coli) and erythromycin (for selection in S. pneumoniae) resistance markers. The strategy for constructing null mutants requires generation of a construct containing a spectinomycinresistance marker (LeBlanc et al, 1991) flanked by PCRgenerated fragments upstream and downstream of the gene to be mutated cloned into pCZA342. Plasmid pCZA342 can replicate in E. coli but not in S. pneumoniae so transformants are screened for an erythromycin-sensitive, spectinomycinresistant phenotype.…”
Section: Methodsmentioning
confidence: 99%
“…In the vicR mutant, there was no transcription termination sequence between the aad gene, which included its native promoter (LeBlanc et al, 1991), and the 39 fragment of the interrupted vicR gene. The transcript levels of vicK and vicX in vicR : : aad were down-regulated compared with the wt strain (Fig.…”
Section: Genes Potentially Regulated By Vicrkmentioning
confidence: 99%